In accordance with applicable privacy legislation, the company Kedrion S.p.a., controller of the data acquired via this website, hereby informs the user that said website does not use profiling cookies to send advertising messages tuned to preferences expressed when browsing the internet. This website installs third party cookies. Continuing to browse, including by scrolling down and clicking on website elements, equates to consent.
For more information, also as regards the technical cookies used by the website and to refuse consent to the installation of individual cookies, please refer to the complete cookies disclosure.
You are now leaving www.kedrion.it. Medical information including licensed uses may be different outside of Italy.
NO
YES
- About Us
- Expertise
- Therapies
- Italian partnership
- Donors
- News Room
- Contact
- Careers
- social network
Therapeutic areas
The Kedrion portfolio of plasma-derived therapies treats a range of disorders and conditions from Albumin for critical care to Anti-D i.m. Immunoglobulin (RhoGAM®) to prevent hemolytic disease in the newborn.
Our continuing commitment to research, development and innovation, along with our growing industrial capacity and expanding international market presence, contributes to an ever-greater access to effective healthcare for people suffering these debilitating conditions.
Our Therapeutic Areas include:
Powered by Drupal
Useful info
Highlights
Where 
© Kedrion 2014 / Kedrion S.p.A Headquarter: Loc. Ai Conti, Castelvecchio Pascoli, 55051-Barga (LU), Fiscal Code, VAT number and registration number from the Registrar of Companies of Lucca 01779530466 – Economic and Administrative Index number CHAMBER OF COMMERCE, INDUSTRY, HANDICRAFT AND AGRICULTURE OF LUCCA 170535, Share Capital fully paid euro 55.186.279